Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Total Current Liabilities (2016 - 2026)

Healthequity has reported Total Current Liabilities over the past 13 years, most recently at $156.8 million for Q1 2026.

  • For Q1 2026, Total Current Liabilities changed 0.34% year-over-year to $156.8 million; the TTM value through Jan 2026 reached $156.8 million, changed 0.34%, while the annual FY2026 figure was $156.8 million, 0.34% changed from the prior year.
  • Total Current Liabilities for Q1 2026 was $156.8 million at Healthequity, up from $120.6 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $156.8 million in Q1 2026 and troughed at $89.7 million in Q2 2023.
  • A 5-year average of $122.3 million and a median of $117.7 million in 2022 define the central range for Total Current Liabilities.
  • Biggest five-year swings in Total Current Liabilities: plummeted 38.82% in 2022 and later soared 60.58% in 2024.
  • Year by year, Total Current Liabilities stood at $110.4 million in 2022, then dropped by 12.81% to $96.2 million in 2023, then soared by 60.58% to $154.5 million in 2024, then dropped by 21.94% to $120.6 million in 2025, then surged by 30.03% to $156.8 million in 2026.
  • Business Quant data shows Total Current Liabilities for HQY at $156.8 million in Q1 2026, $120.6 million in Q4 2025, and $116.6 million in Q3 2025.